US Stock MarketDetailed Quotes

GTHX G1 Therapeutics

Watchlist
  • 4.225
  • -0.085-1.97%
Trading May 23 13:21 ET
220.89MMarket Cap-7041P/E (TTM)

G1 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
11.82%14.48M
60.84%82.51M
45.10%14.87M
-47.83%12.3M
300.95%42.39M
87.57%12.95M
62.98%51.3M
76.85%10.25M
385.30%23.58M
60.10%10.57M
Operating revenue
11.82%14.48M
60.84%82.51M
45.10%14.87M
-47.83%12.3M
300.95%42.39M
87.57%12.95M
62.98%51.3M
76.85%10.25M
385.30%23.58M
60.10%10.57M
Cost of revenue
-26.05%1.08M
91.97%7.2M
26.61%1.26M
176.87%3.08M
43.85%1.4M
118.09%1.46M
85.91%3.75M
165.24%992K
87.99%1.11M
20.79%976K
Gross profit
16.63%13.4M
58.38%75.32M
47.08%13.62M
-58.94%9.22M
327.09%40.99M
84.29%11.49M
61.42%47.55M
70.75%9.26M
426.48%22.47M
65.58%9.6M
Operating expense
-39.72%22.45M
-37.49%114.84M
-43.84%22.55M
-41.85%25.59M
-36.70%29.47M
-29.77%37.23M
6.87%183.73M
-6.66%40.15M
-3.08%44.01M
5.84%46.56M
Selling and administrative expenses
-30.46%15.13M
-29.16%71.13M
-35.62%15.17M
-31.32%16.78M
-32.21%17.43M
-18.56%21.75M
4.94%100.42M
1.46%23.56M
0.68%24.43M
1.90%25.72M
Research and development costs
-52.73%7.32M
-47.54%43.71M
-55.51%7.38M
-55.00%8.81M
-42.23%12.04M
-41.15%15.48M
9.30%83.32M
-16.18%16.59M
-7.39%19.58M
11.15%20.84M
Operating profit
64.86%-9.05M
70.97%-39.53M
71.09%-8.93M
24.04%-16.37M
131.16%11.52M
44.96%-25.75M
4.41%-136.18M
17.82%-30.89M
47.63%-21.55M
3.22%-36.96M
Net non-operating interest income expense
28.49%-1.7M
21.88%-7.57M
36.66%-1.6M
40.07%-1.53M
12.30%-2.07M
-5.19%-2.37M
-109.43%-9.68M
-22.83%-2.52M
-175.40%-2.55M
-156.75%-2.36M
Non-operating interest income
-60.75%281K
230.61%2.47M
10.67%529K
177.25%585K
1,186.00%643K
7,855.56%716K
1,639.53%748K
5,875.00%478K
2,914.29%211K
455.56%50K
Non-operating interest expense
-35.97%1.98M
-3.78%10.04M
-29.11%2.12M
-23.48%2.12M
12.59%2.71M
36.38%3.09M
123.53%10.43M
45.58%3M
195.93%2.76M
159.65%2.41M
Other net income (expense)
0.38%526K
74,566.67%2.24M
131.22%548K
1,147.92%599K
548.03%569K
438.06%524K
100.87%3K
271.74%237K
163.16%48K
-38.04%-127K
Other non- operating income (expenses)
0.38%526K
74,566.67%2.24M
131.22%548K
1,147.92%599K
548.03%569K
438.06%524K
100.87%3K
271.74%237K
163.16%48K
-38.04%-127K
Income before tax
62.97%-10.22M
69.25%-44.85M
69.92%-9.98M
28.08%-17.3M
125.40%10.02M
43.90%-27.6M
1.06%-145.86M
16.61%-33.17M
42.93%-24.05M
-0.62%-39.45M
Income tax
0
83.24%3.12M
87.53%902K
-25.76%905K
1.31M
0
83.78%1.7M
95.53%481K
279.75%1.22M
0
Net income
62.97%-10.22M
67.49%-47.97M
67.67%-10.88M
27.97%-18.2M
122.08%8.71M
43.90%-27.6M
0.53%-147.56M
15.92%-33.65M
40.49%-25.27M
-0.06%-39.45M
Net income continuous Operations
62.97%-10.22M
67.49%-47.97M
67.67%-10.88M
27.97%-18.2M
122.08%8.71M
43.90%-27.6M
0.53%-147.56M
15.92%-33.65M
40.49%-25.27M
-0.06%-39.45M
Minority interest income
Net income attributable to the parent company
62.97%-10.22M
67.49%-47.97M
67.67%-10.88M
27.97%-18.2M
122.08%8.71M
43.90%-27.6M
0.53%-147.56M
15.92%-33.65M
40.49%-25.27M
-0.06%-39.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
62.97%-10.22M
67.49%-47.97M
67.67%-10.88M
27.97%-18.2M
122.08%8.71M
43.90%-27.6M
0.53%-147.56M
15.92%-33.65M
40.49%-25.27M
-0.06%-39.45M
Basic earnings per share
62.26%-0.2
72.49%-0.93
70.42%-0.21
40.68%-0.35
118.48%0.17
53.91%-0.53
4.52%-3.38
24.47%-0.71
41.00%-0.59
2.13%-0.92
Diluted earnings per share
62.26%-0.2
72.49%-0.93
70.42%-0.21
40.68%-0.35
115.22%0.14
53.91%-0.53
4.52%-3.38
24.47%-0.71
41.00%-0.59
2.13%-0.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 11.82%14.48M60.84%82.51M45.10%14.87M-47.83%12.3M300.95%42.39M87.57%12.95M62.98%51.3M76.85%10.25M385.30%23.58M60.10%10.57M
Operating revenue 11.82%14.48M60.84%82.51M45.10%14.87M-47.83%12.3M300.95%42.39M87.57%12.95M62.98%51.3M76.85%10.25M385.30%23.58M60.10%10.57M
Cost of revenue -26.05%1.08M91.97%7.2M26.61%1.26M176.87%3.08M43.85%1.4M118.09%1.46M85.91%3.75M165.24%992K87.99%1.11M20.79%976K
Gross profit 16.63%13.4M58.38%75.32M47.08%13.62M-58.94%9.22M327.09%40.99M84.29%11.49M61.42%47.55M70.75%9.26M426.48%22.47M65.58%9.6M
Operating expense -39.72%22.45M-37.49%114.84M-43.84%22.55M-41.85%25.59M-36.70%29.47M-29.77%37.23M6.87%183.73M-6.66%40.15M-3.08%44.01M5.84%46.56M
Selling and administrative expenses -30.46%15.13M-29.16%71.13M-35.62%15.17M-31.32%16.78M-32.21%17.43M-18.56%21.75M4.94%100.42M1.46%23.56M0.68%24.43M1.90%25.72M
Research and development costs -52.73%7.32M-47.54%43.71M-55.51%7.38M-55.00%8.81M-42.23%12.04M-41.15%15.48M9.30%83.32M-16.18%16.59M-7.39%19.58M11.15%20.84M
Operating profit 64.86%-9.05M70.97%-39.53M71.09%-8.93M24.04%-16.37M131.16%11.52M44.96%-25.75M4.41%-136.18M17.82%-30.89M47.63%-21.55M3.22%-36.96M
Net non-operating interest income expense 28.49%-1.7M21.88%-7.57M36.66%-1.6M40.07%-1.53M12.30%-2.07M-5.19%-2.37M-109.43%-9.68M-22.83%-2.52M-175.40%-2.55M-156.75%-2.36M
Non-operating interest income -60.75%281K230.61%2.47M10.67%529K177.25%585K1,186.00%643K7,855.56%716K1,639.53%748K5,875.00%478K2,914.29%211K455.56%50K
Non-operating interest expense -35.97%1.98M-3.78%10.04M-29.11%2.12M-23.48%2.12M12.59%2.71M36.38%3.09M123.53%10.43M45.58%3M195.93%2.76M159.65%2.41M
Other net income (expense) 0.38%526K74,566.67%2.24M131.22%548K1,147.92%599K548.03%569K438.06%524K100.87%3K271.74%237K163.16%48K-38.04%-127K
Other non- operating income (expenses) 0.38%526K74,566.67%2.24M131.22%548K1,147.92%599K548.03%569K438.06%524K100.87%3K271.74%237K163.16%48K-38.04%-127K
Income before tax 62.97%-10.22M69.25%-44.85M69.92%-9.98M28.08%-17.3M125.40%10.02M43.90%-27.6M1.06%-145.86M16.61%-33.17M42.93%-24.05M-0.62%-39.45M
Income tax 083.24%3.12M87.53%902K-25.76%905K1.31M083.78%1.7M95.53%481K279.75%1.22M0
Net income 62.97%-10.22M67.49%-47.97M67.67%-10.88M27.97%-18.2M122.08%8.71M43.90%-27.6M0.53%-147.56M15.92%-33.65M40.49%-25.27M-0.06%-39.45M
Net income continuous Operations 62.97%-10.22M67.49%-47.97M67.67%-10.88M27.97%-18.2M122.08%8.71M43.90%-27.6M0.53%-147.56M15.92%-33.65M40.49%-25.27M-0.06%-39.45M
Minority interest income
Net income attributable to the parent company 62.97%-10.22M67.49%-47.97M67.67%-10.88M27.97%-18.2M122.08%8.71M43.90%-27.6M0.53%-147.56M15.92%-33.65M40.49%-25.27M-0.06%-39.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 62.97%-10.22M67.49%-47.97M67.67%-10.88M27.97%-18.2M122.08%8.71M43.90%-27.6M0.53%-147.56M15.92%-33.65M40.49%-25.27M-0.06%-39.45M
Basic earnings per share 62.26%-0.272.49%-0.9370.42%-0.2140.68%-0.35118.48%0.1753.91%-0.534.52%-3.3824.47%-0.7141.00%-0.592.13%-0.92
Diluted earnings per share 62.26%-0.272.49%-0.9370.42%-0.2140.68%-0.35115.22%0.1453.91%-0.534.52%-3.3824.47%-0.7141.00%-0.592.13%-0.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg